Particle Therapy Research Center - Partrec

21/04/2026

Vacature Cyclotron Operator/Technicus – PARTREC UMCG

https://werkenbijumcg.nl/-/vacatures/operator-voor-de-agor-deeltjesversneller-voor-medisch-onderzoek/10419-02s000ad6p

20/02/2026

Heb jij zin om te werken in een technisch uitdagende omgeving waar je je kunt ontwikkelen tot allround operateur? Dan is dit je kans!
https://werkenbijumcg.nl/-/vacatures/operators-voor-de-agor-deeltjesversneller-voor-medisch-onderzoek/10419-02s000a6lp

19/12/2025

Great News! PARTREC is excited to contribute to the IMMUNO-PROT consortium, a collaborative project funded by KWF focused on optimizing proton therapy combined with immunotherapy for head and neck cancer.
hashtag hashtag hashtag hashtag hashtag hashtag

🎉 Congratulations to Lara Barazzuol and her team! She has been awarded a €2.96 million grant from the Dutch Cancer Society (KWF Kankerbestrijding) for research on the integration of proton therapy and immunotherapy for head and neck cancer patients. In close collaboration with UMCG colleagues M...

13/02/2025

Exciting job opportunities - Join the PARTREC team at UMCG!
We are thrilled to announce two new openings in our vibrant team:

1 Office Manager: Be the heart of our office! If you have a talent for welcoming new personnel and students, organizing events, and managing administrative tasks like purchasing, finances, and communication, we want you!
https://werkenbijumcg.nl/-/vacatures/office-manager-partrec-umcg/10419-02s0009fsp

2 Technical Specialist - Cyclotron Operator: Dive into the fascinating world of particle accelerators! We are looking for a specialist to operate our cyclotron, handle beam development and application, and work with cryogenic and electric equipment.
https://werkenbijumcg.nl/-/vacatures/cyclotron-operator/-technicus/10419-02s0009fpp

20/11/2024

Redactioneel Artikel van de Maand in "Physics in Medicine and Biology"
(english version below)

Het meest recente artikel van het RIVER-project (iopscience.iop.org/article/10.1088/1361-6560/ad7d5c), met Zahra Ahmadi Ganjeh als eerste auteur, is door het wetenschappelijke tijdschrift “Physics in Medicine and Biology” gekozen als Redactioneel Artikel van de Maand (www.linkedin.com/posts/activity-7259926156726976514-fmJo?utm_source=share&utm_medium=member_desktop). Deze keuze van de redacteur houdt rekening met de reacties en opmerkingen van de recensenten van het manuscript.
Zie ook twitter.com/IOPPBio en twitter.com/ipemnews .

Editor’s Choice Article of the Month in “Physics in Medicine and Biology"

The most recent paper of the RIVER project (iopscience.iop.org/article/10.1088/1361-6560/ad7d5c), with Zahra Ahmadi Ganjeh as first author, was chosen by the scientific journal “Physics in Medicine and Biology" as Editor's Choice Article of the Month (www.linkedin.com/posts/activity-7259926156726976514-fmJo?utm_source=share&utm_medium=member_desktop). This choice by the in-house editor takes into consideration the responses and comments from the reviewers of the manuscript.
See also https://twitter.com/IOPPBio and https://twitter.com/ipemnews .

11/11/2024

Prestigieuze erkenning door de American Association of Physicists in Medicine (English version below)

De resultaten van het RIVER project, gefinancierd door KWF, zijn op de jaarbijeenkomst van de American Association of Physicists in Medicine gehonoreerd met het label "Best in Physics (Therapy)". Het "Best in Physics" label wordt aan slechts 15 van de meer dan 2000 bijdrages op de bijeenkomst toegekend (5 in elk van de categorieën therapie, beeldvorming en interdisciplinair).
Het RIVER project ontwikkelt een methode om de locatie van de dosisverdeling in de patiënt tijdens protonentherapie te meten binnen een fractie van een seconde. Dit laat toe actie te ondernemen indien een bestraling niet volgens plan verloopt. Het beoogde voordeel van deze techniek is dat betere behandelplannen gemaakt kunnen worden, met minder schade aan gezond weefsel en organen, zonder de kwaliteit van de behandeling te compromitteren. Dit leidt tot minder bijwerkingen door de behandeling en een betere kwaliteit van leven voor patiënten.
De recente resultaten werden behaald tijdens experimenten op het Particle Therapy Research Center (PARTREC) en het Groningen Protonentherapiecentrum, beide aan het Universitair Medisch Centrum Groningen. Een samenvatting is te vinden op https://aapm.confex.com/aapm/2024am/meetingapp.cgi/Paper/10239 .

---------------------------

Prestigious recognition by the American Association of Physicists in Medicine

The results of the RIVER project, funded by KWF Dutch Cancer Society, have been honoured with the ‘Best in Physics (Therapy)’ label at the annual meeting of the American Association of Physicists in Medicine. The ‘Best in Physics’ label is awarded to only 15 out of more than 2,000 contributions at the meeting (five in each of the therapy, imaging and interdisciplinary categories).
The RIVER project is developing a method to measure the location of dose distribution in the patient during proton therapy within a fraction of a second. This allows action to be taken if the irradiation does not go according to plan. The intended benefit of this technique is that better treatment plans can be made, with less damage to healthy tissue and organs, without compromising the quality of treatment. This leads to fewer side effects from the treatment and a better quality of life for patients.
The recent results were obtained during experiments at the Particle Therapy Research Centre (PARTREC) and the Groningen Proton Therapy Centre, both at the University Medical Center Groningen. A summary can be found at https://aapm.confex.com/aapm/2024am/meetingapp.cgi/Paper/10239 .

02/10/2024

https://werkenbijumcg.nl/-/vacatures/cyclotron-operator-of-technicus/10419-02s00095wp

Gezocht: Operators voor de AGOR-deeltjesversneller voor medisch onderzoek.

25/06/2024

We are pleased to announce that after almost a year of a technical shutdown we have successfully extracted the first beams from our accelerator AGOR. During the shutdown period a number of upgrades have been implemented in order to improve the beam delivery reliability and to enable the beams for the two new major infrastructures at PARTREC – the new unique pre-clinical IMPACT platform, and the nuclear physics experiment NEXT. In the coming weeks we plan to continue the beam development for a variety of proton and ion beams. So in the coming months we look forward to restarting our routine operation in a full scope and to expanding our capabilities.

23/04/2024

https://werkenbijumcg.nl/-/vacatures/it-software-developer-and-system-engineer/10419-02s0008upp

29/03/2024

Vacature Elektronicus:

https://werkenbijumcg.nl/-/vacatures/elektronicus/10419-02s0008sap